The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.

Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,

Vaccinating livestock and poultry for the H5 series of avian influenza viruses does not have support from the entire ag sector. Friday, Zoetis announced USDA issued a conditional license for it’s killed virus-derived vaccine labeled for use in chickens.

Butter themed license plates? Listeria outbreak in nursing homes? $20M in frozen farmer funds released? Check out these headlines and more.

The US Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) has issued a conditional license for an avian influenza vaccine, H5N2 subtype, killed virus. The vaccine, manufactured by Zoetis, is labeled for use in chickens.

USDA is working to get more eggs into the supply chain in the short-term, but U.S. Agriculture Secretary Brooke Rollins says a team is focused on coming up with a long-term strategy to combat avian flu.

There is new hope when it comes to egg prices. A company producing a bird flu vaccine has now been granted conditional approval from the United States Department of Agriculture. While this current strain of the avian flu has been top of mind for the past few months,

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.

Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.